Concepedia

Matthew J. Arango

MJ

5

Publications

85

Citations

5

H-Index

2015

Active since

Affiliations

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute(Current)

The Ohio State University

Cleveland Clinic

The Ohio State University Wexner Medical Center

Matthew J. Arango is an author at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute specializing in medicine, immunology, and vascular biology.

ORCID

Top concepts

Publications per year

2015–2024

5

Publications

5

Gemcitabine-Associated Thrombotic Microangiopathy: Response to Complement Inhibition and Reinitiation of Gemcitabine

Jeffrey L. Turner, Joshua Reardon, Tanios Bekaii‐Saab et al. · Clinical Colorectal Cancer · 2016 · 24 citations

, , +6

Comparison of conventional versus liposomal irinotecan in combination with fluorouracil for advanced pancreatic cancer: a single-institution experience

Justin Tossey, Joshua Reardon, Jeffrey VanDeusen et al. · Medical Oncology · 2019 · 23 citations · Full text

, , +7

Delayed Presentation of Nitroprusside-Induced Cyanide Toxicity

Chiedozie Udeh, Michael Ting, Matthew J. Arango et al. · The Annals of Thoracic Surgery · 2015 · 18 citations · Full text

First-line gemcitabine plus nab-paclitaxel versus FOLFIRINOX for metastatic pancreatic cancer in a real-world population

Alycia Hatashima, Matthew J. Arango, Joshua Reardon et al. · Future Oncology · 2022 · 10 citations · Full text

Best Practices for Delivering Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma

Jordan M. Cloyd, Angela Sarna, Matthew J. Arango et al. · JAMA Surgery · 2024 · 10 citations · Full text

Rows per page

1–5 of 5